Joanne Bryce

Experience

• Interim Chief Financial Officer

  SiteOne Therapeutics, Inc. • Current • Mar 2024 - Present

  • Participated in deal negotiations and managed diligence activities for the billion acquisition of SiteOne by Eli Lilly and Company • Manage all finance and human resources operations of the company • Implemented systems, policies and financial reporting to support company growth

• 

  Chief Financial Officer

  Disc Medicine • Previous • Sep 2021 - Feb 2024

  • Led Disc’s reverse merger with Gemini Therapeutics in December 2022, including negotiation of valuation, terms of merger agreement, reverse stock split and transition to a public company. • Raised over $500M through the reverse merger, a registered direct offering with Bain Capital, a follow-on public offering, At-the Market (ATM)…

• Additional experience 1
• Additional experience 2